# ATLAS (AltaValve) Pivotal Trial

Study · id `cardio:ct-nct06465745` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06465745](<https://clinicaltrials.gov/study/NCT06465745>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06465745

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

## Technical summary

Registry record NCT06465745. Non-randomized; no masking; primary purpose treatment. Start 2024-09-03 (actual); primary completion 2029-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT06465745, source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)
- Started: 2024-09-03 (actual) (ClinicalTrials.gov record NCT06465745, source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)
- Primary completion: 2029-09 (anticipated) (ClinicalTrials.gov record NCT06465745, source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)
- Completion: 2031-09 (anticipated) (ClinicalTrials.gov record NCT06465745, source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)
- Countries: United States; Canada; France; Germany; Greece; Poland; Spain (ClinicalTrials.gov record NCT06465745, source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06465745-2026-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: ATLAS (AltaValve) Pivotal Trial
- Acronym: ATLAS
- Condition: Mitral Regurgitation
- Condition: Mitral Insufficiency
- Condition: Mitral Valve Incompetence
- Condition: Mitral Valve Regurgitation
- Condition: Mitral Incompetence
- Intervention (Device): AltaValve System.
- Lead sponsor: 4C Medical Technologies, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)

## Provenance

Content hash: f23621b29f94e2d840e4cbe870a06a35367938ecb22466d2d26cbead028ccb05
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
